Abeer Mohamed Abdelrazik

Abeer Mohamed Abdelrazik

Auto-generated profile, based on publicly available information

Abeer Mohamed Abdelrazik

Clinical Pathology Department, Faculty of Medicine, Fayoum University, Egypt

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2016 in Transfusion
Verified
Journal Article
Closed access
PDF file
AAAbeer Mohamed Abdelrazik
Abeer Mohamed Abdelrazik
SEShahira Morsy Elshafie
Shahira Morsy Elshafie
MSManal Niazi El Said
Manal Niazi El Said
GAGhada M. Ezzat Ahmed
Ghada M. Ezzat Ahmed
AAAl‐Kassem Ahmed Al‐Gamil
Al‐Kassem Ahmed Al‐Gamil
ASAhmed Ali Badie Sady
Ahmed Ali Badie Sady

7 December 2020 in Laboratory Medicine
Verified
Journal Article
Closed access
AAAbeer Mohamed Abdelrazik
Abeer Mohamed Abdelrazik
SEShahira Morsy Elshafie
Shahira Morsy Elshafie
HAHossam M Abdelaziz
Hossam M Abdelaziz
Objective: Because of the rapidly emerging SARS-CoV-2 pandemic and its wide public health challenges, rapid diagnosis is essential to decrease the spread. Antigen-based rapid detection tests are available; however, insufficient data about their performance are available. Methods: The lateral-flow immunochromatographic BIOCREDIT COVID-19 antigen test was evaluated using nasopharyngeal swabs in a viral transport medium from patients with confirmed infection, contacts, and exposed healthcare professionals at Fayoum University Hospital in Egypt. Test performance was determined in comparison to the SARS-CoV-2 real-time reverse-transcription polymerase chain reaction (RT-PCR) test. Results: Three hundred ten specimens from 3 categories—patients with confirmed diagnoses of COVID-19, contacts, and exposed healthcare professionals—were included; 188 specimens were RT-PCR-positive, from which 81 were detected by rapid antigen test. Overall sensitivity was 43.1%. Sensitivity was significantly higher in specimens with high viral loads. Conclusion: Poor sensitivity of the BIOCREDIT COVID-19 test does not permit its use for diagnosis, and it can only be used in conjunction with RT-PCR for screening.

30 January 2013 in Transfusion
Verified
Journal Article
Closed access
PDF file
AAAbeer Mohamed Abdelrazik
Abeer Mohamed Abdelrazik
SEShahira Morsy Elshafie
Shahira Morsy Elshafie
GAGhada M. Ezzat Ahmed
Ghada M. Ezzat Ahmed
HAHossam M. Abdelaziz
Hossam M. Abdelaziz

1 February 2016 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
PDF file
AAAbeer Mohamed Abdelrazik
Abeer Mohamed Abdelrazik
GAGhada M. Ezzat Ahmed
Ghada M. Ezzat Ahmed

30 August 2015 in Transfusion
Verified
Journal Article
Closed access
PDF file
AAAbeer Mohamed Abdelrazik
Abeer Mohamed Abdelrazik
MSManal Niazi El Said
Manal Niazi El Said
HAHossam Eldin M. Abdelaziz
Hossam Eldin M. Abdelaziz
HBHaithm Mohannd Badran
Haithm Mohannd Badran
EEEman Yousief Ali Abd Elal
Eman Yousief Ali Abd Elal

1 August 2018 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
AAAbeer Mohamed Abdelrazik
Abeer Mohamed Abdelrazik
HAHanan Elsayed Abozaid
Hanan Elsayed Abozaid
KMKarim Montasser
Karim Montasser